Breaking News - The Fly

Open Search

SNDX

Syndax

$

()

Syndax management to meet with BTIG

SNDX

4/11/2024 - 04:55am

Syndax management to meet with BTIG

SNDX

4/10/2024 - 04:55am

Syndax management to meet with BTIG

SNDX

4/9/2024 - 04:55am

Syndax presents 'positive' results from AUGMENT-101 trial of Revumenib

SNDX

4/8/2024 - 07:06am

Syndax management to meet with BTIG

SNDX

4/3/2024 - 13:50pm

Syndax completes enrollment in AUGMENT-101 trial

SNDX

3/28/2024 - 07:07am

Syndax granted Priority Review for NDA for revumenib by FDA

SNDX

3/26/2024 - 16:07pm

Syndax price target raised by $3 at JPMorgan, here's why

SNDX

3/20/2024 - 07:39am

Syndax names Steven Closter as Chief Commercial Officer

SNDX

3/18/2024 - 07:05am

Syndax files automatic mixed securities shelf

SNDX

2/27/2024 - 17:39pm

Syndax sees FY24 research and development expenses $240M-$260M

SNDX

2/27/2024 - 16:23pm

Syndax Q1 research and development expenses $56M-$62M

SNDX

2/27/2024 - 16:22pm

Syndax reports Q4 EPS ($1.00), consensus (99c)

SNDX

2/27/2024 - 16:21pm

Incyte says FDA grants priority review for axatilimab

INCY , SNDX

2/27/2024 - 16:13pm

Syndax just downgraded at Scotiabank, here's why

SNDX , KURA

1/31/2024 - 07:11am